Picture of Subgen AI AB logo

SUBGEN Subgen AI AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Aegirbio And Lifeassays Are Proposed To Be Merged

Jan 25 (Reuters) - Aegirbio AB  AEGIR.ST :
    * AEGIRBIO AND LIFEASSAYS ARE PROPOSED TO BE MERGED
    * MERGER REQUIRES, AMONG OTHER THINGS, APPROVALS AT EGM OF
BOTH
COS
    * SHAREHOLDERS IN LIFEASSAYS WILL RECEIVE ABOUT 0.0616
SHARES IN
AEGIRBIO IN MERGER CONSIDERATION FOR EACH SHARE HELD IN
LIFEASSAYS
    * BOARDS HAVE INVESTIGATED CONSEQUENCES OF A MERGER AND SEE
STRATEGIC ADVANTAGE WITH A MERGER OF AEGIRBIO AND LIFEASSAYS
    * MERGER IS EXPECTED TO CREATE VALUE FOR SHAREHOLDERS IN NEW
AEGIRBIO THROUGH SYNERGIES IN FORM OF A CLEARER COMPANY
STRUCTURE
    * FOLLOWING  COMPLETION OF  MERGER, MARTIN LINDE IS EXPECTED
TO BE
CEO OF NEW AEGIRBIO.
    * IF APPROVED, MERGER IS EXPECTED TO BE REGISTERED ON JUNE
1, 2021

Source text for Eikon:  ID:nWkr89kzhj 
Further company coverage:  AEGIR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Subgen AI AB

See all news